Related Experiment Videos
Microsatellite Instability-High Somatic-Type Malignancy Arising From a Primary Retroperitoneal Germ Cell Tumor: A
Gaku Hayashi1, Tomokazu Kimura1, Satoshi Inoue1
1Department of Urology Nagoya University Graduate School of Medicine Nagoya City Japan.
Introduction:
Immune checkpoint inhibitors have shown only limited clinical efficacy in germ cell tumors (GCTs), underscoring the need for predictive biomarkers such as microsatellite instability-high (MSI-high). We report a rare case of mixed-type GCTs treated with chemotherapy, in which the somatic-type malignancy (STM) component was found to be MSI-high.
Case Presentation:
A 55-year-old man presented with a retroperitoneal mass, and an open biopsy revealed a mixed GCT. He was diagnosed with primary retroperitoneal GCT and treated with four cycles of bleomycin, etoposide, and cisplatin chemotherapy. Fourteen months later, retroperitoneal lymph node enlargement was observed, and retroperitoneal lymph node dissection revealed an STM. Six months later, local recurrence had occurred. MSI testing of the resected recurrent tumor demonstrated an MSI-high status.
Conclusion:
This case illustrates that careful selection of tissue specimens and appropriate timing of MSI testing are essential to identify potentially actionable cases in patients with GCTs.
Insights
Microsatellite instability-high (MSI-high) status was identified in a rare somatic-type malignancy component of germ cell tumors (GCTs). This finding highlights the importance of MSI testing for potential targeted therapies in GCT patients.
Area of Science:
- Oncology
- Genetics
- Biomarkers
Background:
- Immune checkpoint inhibitors show limited efficacy in germ cell tumors (GCTs).
- Predictive biomarkers are needed to guide GCT treatment.
- Microsatellite instability-high (MSI-high) is a potential biomarker.
Purpose of the Study:
- To report a rare case of mixed-type GCTs with an MSI-high somatic-type malignancy (STM) component.
- To emphasize the importance of MSI testing in GCTs.
Main Methods:
- Case presentation of a 55-year-old man with a retroperitoneal mass.
- Diagnosis of mixed GCT and treatment with chemotherapy.
- Identification of STM component and subsequent MSI testing.
Main Results:
- The somatic-type malignancy component of the mixed GCT was found to be MSI-high.
- MSI testing of the recurrent tumor confirmed MSI-high status.
Conclusions:
- Careful tissue selection and timely MSI testing are crucial for identifying actionable cases in GCT patients.
- MSI-high status in the STM component of GCTs may have therapeutic implications.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...